

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | protein-chromophore linkage (GO:0018298) | 9.93005362 |
| 2 | positive regulation of guanylate cyclase activity (GO:0031284) | 9.28966706 |
| 3 | * visual perception (GO:0007601) | 8.70082447 |
| 4 | * sensory perception of light stimulus (GO:0050953) | 8.60213265 |
| 5 | regulation of guanylate cyclase activity (GO:0031282) | 8.38160186 |
| 6 | cellular response to light stimulus (GO:0071482) | 7.63016414 |
| 7 | photoreceptor cell differentiation (GO:0046530) | 7.30068984 |
| 8 | eye photoreceptor cell differentiation (GO:0001754) | 7.30068984 |
| 9 | detection of external stimulus (GO:0009581) | 7.14629911 |
| 10 | detection of abiotic stimulus (GO:0009582) | 7.01152850 |
| 11 | retina development in camera-type eye (GO:0060041) | 6.57026810 |
| 12 | regulation of cGMP metabolic process (GO:0030823) | 6.07285842 |
| 13 | positive regulation of cGMP biosynthetic process (GO:0030828) | 5.48384254 |
| 14 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 5.45434510 |
| 15 | regulation of cGMP biosynthetic process (GO:0030826) | 5.14034850 |
| 16 | cellular response to radiation (GO:0071478) | 4.95946197 |
| 17 | positive regulation of cGMP metabolic process (GO:0030825) | 4.84253715 |
| 18 | nonmotile primary cilium assembly (GO:0035058) | 4.80870912 |
| 19 | detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580) | 4.70402471 |
| 20 | cell morphogenesis involved in neuron differentiation (GO:0048667) | 4.58384918 |
| 21 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 4.51030886 |
| 22 | regulation of G-protein coupled receptor protein signaling pathway (GO:0008277) | 4.44446882 |
| 23 | neuronal action potential propagation (GO:0019227) | 4.34624551 |
| 24 | neuron fate determination (GO:0048664) | 4.32802729 |
| 25 | behavioral response to nicotine (GO:0035095) | 4.32750268 |
| 26 | estrogen biosynthetic process (GO:0006703) | 4.23295923 |
| 27 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 4.17944074 |
| 28 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.15693776 |
| 29 | regulation of clathrin-mediated endocytosis (GO:2000369) | 4.12212094 |
| 30 | * sensory perception (GO:0007600) | 4.11066002 |
| 31 | primitive streak formation (GO:0090009) | 3.93744521 |
| 32 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.92581445 |
| 33 | response to light stimulus (GO:0009416) | 3.91097060 |
| 34 | neurofilament cytoskeleton organization (GO:0060052) | 3.90356380 |
| 35 | prenylation (GO:0097354) | 3.88908654 |
| 36 | protein prenylation (GO:0018342) | 3.88908654 |
| 37 | cerebral cortex radially oriented cell migration (GO:0021799) | 3.88055951 |
| 38 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.82766114 |
| 39 | neuron development (GO:0048666) | 3.71635660 |
| 40 | * adaptation of signaling pathway (GO:0023058) | 3.71022924 |
| 41 | tongue development (GO:0043586) | 3.67201823 |
| 42 | positive regulation of gastrulation (GO:2000543) | 3.65633052 |
| 43 | synaptic transmission, cholinergic (GO:0007271) | 3.62525881 |
| 44 | somite rostral/caudal axis specification (GO:0032525) | 3.59397496 |
| 45 | regulation of feeding behavior (GO:0060259) | 3.57338590 |
| 46 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.52874215 |
| 47 | tachykinin receptor signaling pathway (GO:0007217) | 3.44258636 |
| 48 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.39929949 |
| 49 | piRNA metabolic process (GO:0034587) | 3.39900357 |
| 50 | protein localization to synapse (GO:0035418) | 3.39055995 |
| 51 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.38833225 |
| 52 | response to dietary excess (GO:0002021) | 3.37471091 |
| 53 | negative regulation of receptor-mediated endocytosis (GO:0048261) | 3.34092126 |
| 54 | retina homeostasis (GO:0001895) | 3.32760331 |
| 55 | response to amphetamine (GO:0001975) | 3.31798968 |
| 56 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.29186341 |
| 57 | regulation of dopamine metabolic process (GO:0042053) | 3.24937961 |
| 58 | regulation of catecholamine metabolic process (GO:0042069) | 3.24937961 |
| 59 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 3.23717814 |
| 60 | hindbrain development (GO:0030902) | 3.19901442 |
| 61 | neuron recognition (GO:0008038) | 3.18558196 |
| 62 | short-term memory (GO:0007614) | 3.16238476 |
| 63 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.15546471 |
| 64 | mitochondrion distribution (GO:0048311) | 3.13768676 |
| 65 | positive regulation of action potential (GO:0045760) | 3.11917021 |
| 66 | postsynaptic membrane organization (GO:0001941) | 3.11119657 |
| 67 | retinoid metabolic process (GO:0001523) | 3.10423550 |
| 68 | membrane hyperpolarization (GO:0060081) | 3.09817111 |
| 69 | axoneme assembly (GO:0035082) | 3.09443307 |
| 70 | presynaptic membrane assembly (GO:0097105) | 3.09226453 |
| 71 | exploration behavior (GO:0035640) | 3.07051213 |
| 72 | regulation of alternative mRNA splicing, via spliceosome (GO:0000381) | 3.06999286 |
| 73 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.06969980 |
| 74 | sympathetic nervous system development (GO:0048485) | 3.06739223 |
| 75 | regulation of respiratory system process (GO:0044065) | 3.06130989 |
| 76 | positive regulation of neurotransmitter transport (GO:0051590) | 3.06059357 |
| 77 | glycine transport (GO:0015816) | 3.05369428 |
| 78 | central nervous system neuron axonogenesis (GO:0021955) | 3.05073459 |
| 79 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 3.04501480 |
| 80 | behavioral response to ethanol (GO:0048149) | 3.03078592 |
| 81 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.01763773 |
| 82 | regulation of collateral sprouting (GO:0048670) | 3.01629462 |
| 83 | nucleobase catabolic process (GO:0046113) | 3.00991933 |
| 84 | regulation of cellular respiration (GO:0043457) | 2.99552474 |
| 85 | cell migration in hindbrain (GO:0021535) | 2.98800602 |
| 86 | positive regulation of G-protein coupled receptor protein signaling pathway (GO:0045745) | 2.96951254 |
| 87 | chemosensory behavior (GO:0007635) | 2.95853200 |
| 88 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.94876462 |
| 89 | regulation of penile erection (GO:0060405) | 2.94285117 |
| 90 | CDP-diacylglycerol metabolic process (GO:0046341) | 2.93069061 |
| 91 | dendrite morphogenesis (GO:0048813) | 2.89541442 |
| 92 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 2.88896981 |
| 93 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 2.88896981 |
| 94 | phospholipid translocation (GO:0045332) | 2.88741912 |
| 95 | lipid translocation (GO:0034204) | 2.88741912 |
| 96 | regulation of neurotransmitter uptake (GO:0051580) | 2.88568581 |
| 97 | regulation of DNA methylation (GO:0044030) | 2.87957902 |
| 98 | diterpenoid metabolic process (GO:0016101) | 2.87202244 |
| 99 | response to histamine (GO:0034776) | 2.86860645 |
| 100 | neuron-neuron synaptic transmission (GO:0007270) | 2.86486173 |
| 101 | serotonin metabolic process (GO:0042428) | 2.85988919 |
| 102 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.85712241 |
| 103 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.82889017 |
| 104 | L-amino acid import (GO:0043092) | 2.81730050 |
| 105 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.81242917 |
| 106 | positive regulation of dendritic spine development (GO:0060999) | 2.80316388 |
| 107 | positive regulation of cell cycle G2/M phase transition (GO:1902751) | 2.80044348 |
| 108 | positive regulation of G2/M transition of mitotic cell cycle (GO:0010971) | 2.80044348 |
| 109 | gamma-aminobutyric acid transport (GO:0015812) | 2.79455815 |
| 110 | specification of organ identity (GO:0010092) | 2.79263425 |
| 111 | positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742) | 2.79180267 |
| 112 | dopamine biosynthetic process (GO:0042416) | 2.78773931 |
| 113 | negative regulation of appetite (GO:0032099) | 2.76593927 |
| 114 | negative regulation of response to food (GO:0032096) | 2.76593927 |
| 115 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 2.76546559 |
| 116 | regulation of respiratory gaseous exchange (GO:0043576) | 2.76275229 |
| 117 | regulation of female gonad development (GO:2000194) | 2.75962171 |
| 118 | multicellular organism reproduction (GO:0032504) | 2.75728517 |
| 119 | detection of chemical stimulus involved in sensory perception of taste (GO:0050912) | 2.69878986 |
| 120 | axonal fasciculation (GO:0007413) | 2.69115468 |
| 121 | synaptic vesicle maturation (GO:0016188) | 2.68959223 |
| 122 | response to radiation (GO:0009314) | 2.68617153 |
| 123 | glycerophospholipid catabolic process (GO:0046475) | 2.68588306 |
| 124 | DNA methylation involved in gamete generation (GO:0043046) | 2.68467468 |
| 125 | dopaminergic neuron differentiation (GO:0071542) | 2.68170307 |
| 126 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.66957223 |
| 127 | adult walking behavior (GO:0007628) | 2.66728836 |
| 128 | terpenoid metabolic process (GO:0006721) | 2.62898832 |
| 129 | response to cocaine (GO:0042220) | 2.62835249 |
| 130 | establishment of mitochondrion localization (GO:0051654) | 2.62027454 |
| 131 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.60937337 |
| 132 | post-embryonic morphogenesis (GO:0009886) | 2.60442937 |
| 133 | glycosphingolipid biosynthetic process (GO:0006688) | 2.59933822 |
| 134 | positive regulation of ERBB signaling pathway (GO:1901186) | 2.59895814 |
| 135 | membrane depolarization during action potential (GO:0086010) | 2.59525165 |
| 136 | presynaptic membrane organization (GO:0097090) | 2.59358244 |
| 137 | detection of mechanical stimulus involved in sensory perception (GO:0050974) | 2.58801197 |
| 138 | transmission of nerve impulse (GO:0019226) | 2.58265315 |
| 139 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.57144098 |
| 140 | glutamate receptor signaling pathway (GO:0007215) | 2.55466800 |
| 141 | positive regulation of synapse assembly (GO:0051965) | 2.55428957 |
| 142 | retinol metabolic process (GO:0042572) | 2.54674443 |
| 143 | icosanoid secretion (GO:0032309) | 2.52268161 |
| 144 | arachidonic acid secretion (GO:0050482) | 2.52268161 |
| 145 | regulation of meiosis I (GO:0060631) | 2.52171427 |
| 146 | cellular response to abiotic stimulus (GO:0071214) | 2.52070971 |
| 147 | axon extension (GO:0048675) | 2.51556233 |
| 148 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.51448770 |
| 149 | detection of chemical stimulus involved in sensory perception (GO:0050907) | 2.49974085 |
| 150 | lipoprotein transport (GO:0042953) | 2.42369661 |
| 151 | negative regulation of cation channel activity (GO:2001258) | 2.41742087 |
| 152 | dopamine receptor signaling pathway (GO:0007212) | 2.40362633 |
| 153 | righting reflex (GO:0060013) | 2.37821393 |
| 154 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.36162122 |
| 155 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.36162122 |
| 156 | mitochondrion transport along microtubule (GO:0047497) | 2.35719139 |
| 157 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.35719139 |
| 158 | protein heterotetramerization (GO:0051290) | 2.33393414 |
| 159 | startle response (GO:0001964) | 2.31609632 |
| 160 | positive regulation of cyclase activity (GO:0031281) | 2.29221947 |
| 161 | behavioral response to cocaine (GO:0048148) | 2.27803864 |
| 162 | synaptic transmission, dopaminergic (GO:0001963) | 2.17795540 |
| 163 | cellular potassium ion homeostasis (GO:0030007) | 2.17213464 |
| 164 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 18.4907488 |
| 165 | rhodopsin mediated signaling pathway (GO:0016056) | 18.1072157 |
| 166 | retinal cone cell development (GO:0046549) | 15.2993487 |
| 167 | photoreceptor cell development (GO:0042461) | 12.4879677 |
| 168 | photoreceptor cell maintenance (GO:0045494) | 12.2089329 |
| 169 | eye photoreceptor cell development (GO:0042462) | 11.8648942 |
| 170 | detection of light stimulus involved in visual perception (GO:0050908) | 11.0541295 |
| 171 | detection of light stimulus involved in sensory perception (GO:0050962) | 11.0541295 |
| 172 | phototransduction (GO:0007602) | 10.7914250 |
| 173 | phototransduction, visible light (GO:0007603) | 10.7912160 |
| 174 | retinal rod cell development (GO:0046548) | 10.3199627 |
| 175 | detection of visible light (GO:0009584) | 10.2691289 |
| 176 | detection of light stimulus (GO:0009583) | 10.1963166 |
| 177 | GMP metabolic process (GO:0046037) | 10.1855308 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.22030599 |
| 2 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 3.48204282 |
| 3 | * CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 3.45686180 |
| 4 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.15474640 |
| 5 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.79429163 |
| 6 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.76754647 |
| 7 | VDR_22108803_ChIP-Seq_LS180_Human | 2.65409169 |
| 8 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.18394753 |
| 9 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.12577921 |
| 10 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.08889728 |
| 11 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.07199313 |
| 12 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.06626817 |
| 13 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 2.02809899 |
| 14 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 2.00458657 |
| 15 | EZH2_22144423_ChIP-Seq_EOC_Human | 10.1018347 |
| 16 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.93688693 |
| 17 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.92132110 |
| 18 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.84719476 |
| 19 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.83920544 |
| 20 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.82560292 |
| 21 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.81955088 |
| 22 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.80748843 |
| 23 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.68582129 |
| 24 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.66364413 |
| 25 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.64085192 |
| 26 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.63291667 |
| 27 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.63117708 |
| 28 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.62026294 |
| 29 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.61776650 |
| 30 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.61466283 |
| 31 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.61175123 |
| 32 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.58966418 |
| 33 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.55623949 |
| 34 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.55036654 |
| 35 | AR_19668381_ChIP-Seq_PC3_Human | 1.53616822 |
| 36 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.53591627 |
| 37 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.53289841 |
| 38 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.51024594 |
| 39 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.49485908 |
| 40 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.47960089 |
| 41 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.47960089 |
| 42 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.44702505 |
| 43 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.44414037 |
| 44 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.44336700 |
| 45 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.43598445 |
| 46 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.43547098 |
| 47 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.43127481 |
| 48 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.40567703 |
| 49 | KDM2B_26808549_Chip-Seq_K562_Human | 1.38318338 |
| 50 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.37170345 |
| 51 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.37090030 |
| 52 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.35942190 |
| 53 | STAT3_23295773_ChIP-Seq_U87_Human | 1.35748860 |
| 54 | TBL1_22424771_ChIP-Seq_293T_Human | 1.35159962 |
| 55 | AR_25329375_ChIP-Seq_VCAP_Human | 1.33773995 |
| 56 | P300_19829295_ChIP-Seq_ESCs_Human | 1.33466839 |
| 57 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.33305751 |
| 58 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.33288573 |
| 59 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.32506805 |
| 60 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.31432392 |
| 61 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.29187266 |
| 62 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.26413894 |
| 63 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.25733331 |
| 64 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.25694039 |
| 65 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.25342963 |
| 66 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.24450506 |
| 67 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.23403871 |
| 68 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.23225810 |
| 69 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.22782121 |
| 70 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.22055729 |
| 71 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.21478593 |
| 72 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.18590357 |
| 73 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.17680609 |
| 74 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.14081725 |
| 75 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.13391090 |
| 76 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.12400528 |
| 77 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.11709204 |
| 78 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.10217341 |
| 79 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.10073079 |
| 80 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.09563336 |
| 81 | TCF4_23295773_ChIP-Seq_U87_Human | 1.08203254 |
| 82 | JUN_21703547_ChIP-Seq_K562_Human | 1.08157097 |
| 83 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.06837892 |
| 84 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.06092795 |
| 85 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.06058545 |
| 86 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.05456446 |
| 87 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.05018811 |
| 88 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04677606 |
| 89 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.04330407 |
| 90 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.04148444 |
| 91 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.03377126 |
| 92 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.03280514 |
| 93 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.03133643 |
| 94 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 1.02648423 |
| 95 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.02309894 |
| 96 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.02167377 |
| 97 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.01683094 |
| 98 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.01321270 |
| 99 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.01321270 |
| 100 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.00683427 |
| 101 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.00409662 |
| 102 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.99854180 |
| 103 | EWS_26573619_Chip-Seq_HEK293_Human | 0.99623911 |
| 104 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.99223073 |
| 105 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98762240 |
| 106 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.98665999 |
| 107 | FUS_26573619_Chip-Seq_HEK293_Human | 0.97474666 |
| 108 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.96029372 |
| 109 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.95924084 |
| 110 | CBP_21632823_ChIP-Seq_H3396_Human | 0.95513055 |
| 111 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.95009965 |
| 112 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.94547277 |
| 113 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.94302638 |
| 114 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.94288713 |
| 115 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.94220162 |
| 116 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.93469540 |
| 117 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.92924300 |
| 118 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.92787533 |
| 119 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.92729952 |
| 120 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.92399116 |
| 121 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.92311848 |
| 122 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.92120145 |
| 123 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.91863666 |
| 124 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.91457384 |
| 125 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.91171066 |
| 126 | * OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.90225499 |
| 127 | CEBPB_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.88714793 |
| 128 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.88661874 |
| 129 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.88541009 |
| 130 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.88479102 |
| 131 | NCOR_22424771_ChIP-Seq_293T_Human | 0.87401437 |
| 132 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.87398080 |
| 133 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.87398080 |
| 134 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.87371291 |
| 135 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.87034282 |
| 136 | KDM2B_26808549_Chip-Seq_REH_Human | 0.86931526 |
| 137 | * MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.86470412 |
| 138 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.86173464 |
| 139 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.86069616 |
| 140 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.85093572 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * MP0005551_abnormal_eye_electrophysiolog | 9.56765451 |
| 2 | MP0005253_abnormal_eye_physiology | 6.97482683 |
| 3 | MP0006072_abnormal_retinal_apoptosis | 6.54945604 |
| 4 | MP0003950_abnormal_plasma_membrane | 3.93477448 |
| 5 | * MP0005195_abnormal_posterior_eye | 3.81980113 |
| 6 | MP0005391_vision/eye_phenotype | 3.39022362 |
| 7 | * MP0001324_abnormal_eye_pigmentation | 3.17961790 |
| 8 | MP0002090_abnormal_vision | 3.05517376 |
| 9 | MP0002638_abnormal_pupillary_reflex | 2.91410627 |
| 10 | MP0002229_neurodegeneration | 2.67422589 |
| 11 | MP0005423_abnormal_somatic_nervous | 2.49042272 |
| 12 | MP0008877_abnormal_DNA_methylation | 2.36547131 |
| 13 | MP0003879_abnormal_hair_cell | 2.22225245 |
| 14 | MP0002736_abnormal_nociception_after | 2.18201969 |
| 15 | MP0002234_abnormal_pharynx_morphology | 2.17914207 |
| 16 | MP0003787_abnormal_imprinting | 2.16003230 |
| 17 | MP0001764_abnormal_homeostasis | 2.14918055 |
| 18 | MP0003011_delayed_dark_adaptation | 11.3175331 |
| 19 | * MP0002752_abnormal_somatic_nervous | 1.89875454 |
| 20 | MP0003121_genomic_imprinting | 1.81405694 |
| 21 | MP0006276_abnormal_autonomic_nervous | 1.76443224 |
| 22 | MP0001986_abnormal_taste_sensitivity | 1.76233210 |
| 23 | MP0003122_maternal_imprinting | 1.67961439 |
| 24 | MP0002735_abnormal_chemical_nociception | 1.60328303 |
| 25 | MP0009379_abnormal_foot_pigmentation | 1.59665546 |
| 26 | MP0001188_hyperpigmentation | 1.58523179 |
| 27 | MP0003718_maternal_effect | 1.53876027 |
| 28 | MP0004133_heterotaxia | 1.51369446 |
| 29 | MP0002653_abnormal_ependyma_morphology | 1.47274105 |
| 30 | MP0004019_abnormal_vitamin_homeostasis | 1.43647638 |
| 31 | MP0002733_abnormal_thermal_nociception | 1.43406186 |
| 32 | MP0000955_abnormal_spinal_cord | 1.39747238 |
| 33 | * MP0002882_abnormal_neuron_morphology | 1.38137197 |
| 34 | MP0000049_abnormal_middle_ear | 1.36824497 |
| 35 | MP0001440_abnormal_grooming_behavior | 1.34340878 |
| 36 | MP0001502_abnormal_circadian_rhythm | 1.20008721 |
| 37 | MP0000569_abnormal_digit_pigmentation | 1.16134907 |
| 38 | MP0003942_abnormal_urinary_system | 1.15627547 |
| 39 | MP0003136_yellow_coat_color | 1.11360291 |
| 40 | MP0003123_paternal_imprinting | 1.09192386 |
| 41 | MP0001293_anophthalmia | 1.06106531 |
| 42 | MP0004233_abnormal_muscle_weight | 1.05168784 |
| 43 | MP0002876_abnormal_thyroid_physiology | 1.05090572 |
| 44 | MP0006292_abnormal_olfactory_placode | 1.04355899 |
| 45 | MP0004885_abnormal_endolymph | 1.03997022 |
| 46 | MP0001984_abnormal_olfaction | 1.03925322 |
| 47 | MP0001529_abnormal_vocalization | 1.03225367 |
| 48 | MP0003119_abnormal_digestive_system | 1.01653988 |
| 49 | MP0002837_dystrophic_cardiac_calcinosis | 1.00747574 |
| 50 | MP0004270_analgesia | 0.99578815 |
| 51 | MP0005197_abnormal_uvea_morphology | 0.97571101 |
| 52 | MP0002751_abnormal_autonomic_nervous | 0.97303607 |
| 53 | MP0001486_abnormal_startle_reflex | 0.94014293 |
| 54 | MP0001485_abnormal_pinna_reflex | 0.90013603 |
| 55 | MP0002233_abnormal_nose_morphology | 0.89133099 |
| 56 | MP0003861_abnormal_nervous_system | 0.88698153 |
| 57 | MP0003938_abnormal_ear_development | 0.87291553 |
| 58 | MP0002069_abnormal_eating/drinking_beha | 0.84643220 |
| 59 | MP0003634_abnormal_glial_cell | 0.82868425 |
| 60 | MP0010030_abnormal_orbit_morphology | 0.81778130 |
| 61 | MP0000427_abnormal_hair_cycle | 0.80295155 |
| 62 | MP0003755_abnormal_palate_morphology | 0.79600743 |
| 63 | MP0003880_abnormal_central_pattern | 0.78703035 |
| 64 | MP0005394_taste/olfaction_phenotype | 0.77615609 |
| 65 | MP0005499_abnormal_olfactory_system | 0.77615609 |
| 66 | MP0003385_abnormal_body_wall | 0.77267603 |
| 67 | MP0002332_abnormal_exercise_endurance | 0.74818285 |
| 68 | MP0002272_abnormal_nervous_system | 0.74586785 |
| 69 | MP0009250_abnormal_appendicular_skeleto | 0.73910454 |
| 70 | MP0002160_abnormal_reproductive_system | 0.73471038 |
| 71 | MP0002210_abnormal_sex_determination | 0.71758496 |
| 72 | MP0002127_abnormal_cardiovascular_syste | 0.70367508 |
| 73 | MP0001299_abnormal_eye_distance/ | 0.66949144 |
| 74 | MP0000534_abnormal_ureter_morphology | 0.66638872 |
| 75 | MP0005187_abnormal_penis_morphology | 0.66115276 |
| 76 | MP0008789_abnormal_olfactory_epithelium | 0.63348901 |
| 77 | MP0004859_abnormal_synaptic_plasticity | 0.62395516 |
| 78 | MP0009046_muscle_twitch | 0.61559364 |
| 79 | MP0001286_abnormal_eye_development | 0.61214694 |
| 80 | MP0002064_seizures | 0.60840186 |
| 81 | MP0002734_abnormal_mechanical_nocicepti | 0.59015269 |
| 82 | MP0003635_abnormal_synaptic_transmissio | 0.56679119 |
| 83 | MP0001963_abnormal_hearing_physiology | 0.56326148 |
| 84 | MP0000465_gastrointestinal_hemorrhage | 0.49204741 |
| 85 | MP0002063_abnormal_learning/memory/cond | 0.46454420 |
| 86 | MP0005376_homeostasis/metabolism_phenot | 0.46182147 |
| 87 | MP0002067_abnormal_sensory_capabilities | 0.44619911 |
| 88 | MP0002572_abnormal_emotion/affect_behav | 0.43531654 |
| 89 | MP0001968_abnormal_touch/_nociception | 0.41815640 |
| 90 | MP0002102_abnormal_ear_morphology | 0.40231667 |
| 91 | MP0004742_abnormal_vestibular_system | 0.40191052 |
| 92 | MP0009745_abnormal_behavioral_response | 0.40171532 |
| 93 | MP0004924_abnormal_behavior | 0.39415463 |
| 94 | MP0005386_behavior/neurological_phenoty | 0.39415463 |
| 95 | MP0004215_abnormal_myocardial_fiber | 0.36020532 |
| 96 | MP0008004_abnormal_stomach_pH | 0.35261599 |
| 97 | MP0005248_abnormal_Harderian_gland | 0.34048015 |
| 98 | MP0010386_abnormal_urinary_bladder | 0.33798585 |
| 99 | MP0000631_abnormal_neuroendocrine_gland | 0.32941426 |
| 100 | MP0000026_abnormal_inner_ear | 0.32211837 |
| 101 | MP0003890_abnormal_embryonic-extraembry | 0.30745204 |
| 102 | MP0004782_abnormal_surfactant_physiolog | 0.30024967 |
| 103 | MP0009780_abnormal_chondrocyte_physiolo | 0.29266429 |
| 104 | MP0003045_fibrosis | 0.29114330 |
| 105 | MP0004085_abnormal_heartbeat | 0.27113491 |
| 106 | MP0008569_lethality_at_weaning | 0.26427642 |
| 107 | MP0004043_abnormal_pH_regulation | 0.25768669 |
| 108 | MP0002697_abnormal_eye_size | 0.25444733 |
| 109 | MP0002184_abnormal_innervation | 0.25319655 |
| 110 | MP0004142_abnormal_muscle_tone | 0.24923961 |
| 111 | MP0002066_abnormal_motor_capabilities/c | 0.24189224 |
| 112 | MP0002152_abnormal_brain_morphology | 0.23587429 |
| 113 | MP0005620_abnormal_muscle_contractility | 0.23368912 |
| 114 | MP0000778_abnormal_nervous_system | 0.23336969 |
| 115 | MP0004145_abnormal_muscle_electrophysio | 0.23326088 |
| 116 | MP0005646_abnormal_pituitary_gland | 0.22159105 |
| 117 | MP0005193_abnormal_anterior_eye | 0.20364779 |
| 118 | MP0001915_intracranial_hemorrhage | 0.20153590 |
| 119 | MP0003632_abnormal_nervous_system | 0.20111439 |
| 120 | MP0004811_abnormal_neuron_physiology | 0.18711235 |
| 121 | MP0005595_abnormal_vascular_smooth | 0.18338214 |
| 122 | MP0003633_abnormal_nervous_system | 0.16941097 |
| 123 | MP0001905_abnormal_dopamine_level | 0.16627194 |
| 124 | MP0003943_abnormal_hepatobiliary_system | 0.16395205 |
| 125 | MP0002928_abnormal_bile_duct | 0.16310260 |
| 126 | MP0002557_abnormal_social/conspecific_i | 0.15207279 |
| 127 | MP0003252_abnormal_bile_duct | 0.14451298 |
| 128 | MP0005076_abnormal_cell_differentiation | 0.14000831 |
| 129 | MP0001661_extended_life_span | 0.13966009 |
| 130 | MP0003631_nervous_system_phenotype | 0.13903557 |
| 131 | MP0003646_muscle_fatigue | 0.12835179 |
| 132 | MP0001501_abnormal_sleep_pattern | 0.12030991 |
| 133 | MP0002108_abnormal_muscle_morphology | 0.11844207 |
| 134 | MP0001970_abnormal_pain_threshold | 0.11616186 |
| 135 | MP0001177_atelectasis | 0.11258127 |
| 136 | MP0001879_abnormal_lymphatic_vessel | 0.08923364 |
| 137 | MP0000001_mammalian_phenotype | 0.08134744 |
| 138 | MP0002909_abnormal_adrenal_gland | 0.07918457 |
| 139 | MP0003638_abnormal_response/metabolism_ | 0.07630636 |
| 140 | MP0003956_abnormal_body_size | 0.07481848 |
| 141 | MP0000749_muscle_degeneration | 0.07326229 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Pigmentary retinal degeneration (HP:0001146) | 8.99131853 |
| 2 | Chorioretinal atrophy (HP:0000533) | 8.95111618 |
| 3 | Dyschromatopsia (HP:0007641) | 8.69145616 |
| 4 | Central scotoma (HP:0000603) | 8.61731505 |
| 5 | Pendular nystagmus (HP:0012043) | 7.97293673 |
| 6 | Abnormality of macular pigmentation (HP:0008002) | 7.89127270 |
| 7 | Scotoma (HP:0000575) | 7.76996030 |
| 8 | Attenuation of retinal blood vessels (HP:0007843) | 7.62467604 |
| 9 | Abolished electroretinogram (ERG) (HP:0000550) | 7.09951078 |
| 10 | Decreased central vision (HP:0007663) | 6.39309876 |
| 11 | Photophobia (HP:0000613) | 5.72088048 |
| 12 | Type II diabetes mellitus (HP:0005978) | 5.67866328 |
| 13 | Vitreoretinal degeneration (HP:0000655) | 5.29298221 |
| 14 | Macular degeneration (HP:0000608) | 5.16282714 |
| 15 | Increased corneal curvature (HP:0100692) | 5.11737696 |
| 16 | Keratoconus (HP:0000563) | 5.11737696 |
| 17 | Myokymia (HP:0002411) | 5.11406387 |
| 18 | Cone-rod dystrophy (HP:0000548) | 5.05860437 |
| 19 | Posterior subcapsular cataract (HP:0007787) | 4.85517234 |
| 20 | Severe visual impairment (HP:0001141) | 4.79595806 |
| 21 | Constricted visual fields (HP:0001133) | 4.66134117 |
| 22 | Choroideremia (HP:0001139) | 4.61228821 |
| 23 | Retinitis pigmentosa (HP:0000510) | 4.46211836 |
| 24 | Limb dystonia (HP:0002451) | 4.34390780 |
| 25 | Focal motor seizures (HP:0011153) | 4.22517531 |
| 26 | Focal seizures (HP:0007359) | 4.15978011 |
| 27 | Shawl scrotum (HP:0000049) | 3.83984312 |
| 28 | Hyperventilation (HP:0002883) | 3.82206114 |
| 29 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 3.80559527 |
| 30 | Septo-optic dysplasia (HP:0100842) | 3.58803041 |
| 31 | Drooling (HP:0002307) | 3.36408217 |
| 32 | Poor eye contact (HP:0000817) | 3.25584534 |
| 33 | Abdominal situs inversus (HP:0003363) | 3.13886497 |
| 34 | Abnormality of abdominal situs (HP:0011620) | 3.13886497 |
| 35 | Excessive salivation (HP:0003781) | 3.08811669 |
| 36 | Action tremor (HP:0002345) | 3.02208655 |
| 37 | Subcapsular cataract (HP:0000523) | 2.97970585 |
| 38 | Bilateral microphthalmos (HP:0007633) | 2.87058656 |
| 39 | Protruding tongue (HP:0010808) | 2.77838568 |
| 40 | Congenital sensorineural hearing impairment (HP:0008527) | 2.74638267 |
| 41 | Amblyopia (HP:0000646) | 2.73896581 |
| 42 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 2.73016500 |
| 43 | High anterior hairline (HP:0009890) | 2.64054189 |
| 44 | Tented upper lip vermilion (HP:0010804) | 2.60998993 |
| 45 | Optic disc pallor (HP:0000543) | 2.59211244 |
| 46 | Wide nasal bridge (HP:0000431) | 2.54452408 |
| 47 | Abnormal eating behavior (HP:0100738) | 2.54208222 |
| 48 | Annular pancreas (HP:0001734) | 2.53714119 |
| 49 | Impaired social interactions (HP:0000735) | 2.53017496 |
| 50 | Abnormal social behavior (HP:0012433) | 2.53017496 |
| 51 | Abnormal hair whorl (HP:0010721) | 2.46838583 |
| 52 | Fair hair (HP:0002286) | 2.44436952 |
| 53 | Hemiparesis (HP:0001269) | 2.41654243 |
| 54 | Hepatoblastoma (HP:0002884) | 2.41342920 |
| 55 | * Progressive visual loss (HP:0000529) | 2.41259468 |
| 56 | Dialeptic seizures (HP:0011146) | 2.34505778 |
| 57 | Gait imbalance (HP:0002141) | 2.32322387 |
| 58 | Tubular atrophy (HP:0000092) | 2.31851158 |
| 59 | Congenital primary aphakia (HP:0007707) | 2.30338564 |
| 60 | Abnormality of the renal medulla (HP:0100957) | 2.25855688 |
| 61 | Epileptiform EEG discharges (HP:0011182) | 2.23618788 |
| 62 | Abnormal ciliary motility (HP:0012262) | 2.22752232 |
| 63 | Abnormality of the labia minora (HP:0012880) | 2.19889209 |
| 64 | Atonic seizures (HP:0010819) | 2.19500041 |
| 65 | Hypsarrhythmia (HP:0002521) | 2.17608248 |
| 66 | Absent septum pellucidum (HP:0001331) | 2.17250819 |
| 67 | Optic nerve hypoplasia (HP:0000609) | 2.15463243 |
| 68 | EEG with generalized epileptiform discharges (HP:0011198) | 2.14934521 |
| 69 | Exotropia (HP:0000577) | 2.13958906 |
| 70 | Aplasia/Hypoplasia affecting the fundus (HP:0008057) | 2.10397528 |
| 71 | Generalized tonic-clonic seizures (HP:0002069) | 2.10397490 |
| 72 | Nephrogenic diabetes insipidus (HP:0009806) | 2.05635013 |
| 73 | Osteomalacia (HP:0002749) | 2.04199270 |
| 74 | Pachygyria (HP:0001302) | 2.03359296 |
| 75 | Fetal akinesia sequence (HP:0001989) | 2.03322903 |
| 76 | Poor suck (HP:0002033) | 2.00851067 |
| 77 | Congenital stationary night blindness (HP:0007642) | 14.0844152 |
| 78 | Bony spicule pigmentary retinopathy (HP:0007737) | 12.0313547 |
| 79 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 10.7652085 |
| 80 | Abnormal rod and cone electroretinograms (HP:0008323) | 10.2344483 |
| 81 | Medial flaring of the eyebrow (HP:0010747) | 1.96762154 |
| 82 | Absent speech (HP:0001344) | 1.92639218 |
| 83 | Esotropia (HP:0000565) | 1.92236921 |
| 84 | Abnormality of the renal cortex (HP:0011035) | 1.92096581 |
| 85 | Absence seizures (HP:0002121) | 1.88658117 |
| 86 | Maternal diabetes (HP:0009800) | 1.87239404 |
| 87 | Acute lymphatic leukemia (HP:0006721) | 1.85494766 |
| 88 | Palpebral edema (HP:0100540) | 1.83145233 |
| 89 | Lissencephaly (HP:0001339) | 1.83116343 |
| 90 | Impulsivity (HP:0100710) | 1.81808313 |
| 91 | Polyphagia (HP:0002591) | 1.77481057 |
| 92 | Hyperthyroidism (HP:0000836) | 1.77480078 |
| 93 | Poor coordination (HP:0002370) | 1.77157541 |
| 94 | Gastroesophageal reflux (HP:0002020) | 1.75890965 |
| 95 | Papillary thyroid carcinoma (HP:0002895) | 1.73208961 |
| 96 | Torticollis (HP:0000473) | 1.72917779 |
| 97 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.72676502 |
| 98 | Abnormality of the septum pellucidum (HP:0007375) | 1.72118155 |
| 99 | Retinal dysplasia (HP:0007973) | 1.71811922 |
| 100 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.71168361 |
| 101 | Inappropriate behavior (HP:0000719) | 1.70989387 |
| 102 | Sensory axonal neuropathy (HP:0003390) | 1.70318552 |
| 103 | Hypoventilation (HP:0002791) | 1.67193391 |
| 104 | Abnormal drinking behavior (HP:0030082) | 1.65948025 |
| 105 | Polydipsia (HP:0001959) | 1.65948025 |
| 106 | Polar cataract (HP:0010696) | 1.65690869 |
| 107 | Generalized hypopigmentation of hair (HP:0011358) | 1.65261854 |
| 108 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.64129109 |
| 109 | Narrow forehead (HP:0000341) | 1.64098588 |
| 110 | Thyroid-stimulating hormone excess (HP:0002925) | 1.63967159 |
| 111 | Horizontal nystagmus (HP:0000666) | 1.63637684 |
| 112 | Optic atrophy (HP:0000648) | 1.62588328 |
| 113 | CNS hypomyelination (HP:0003429) | 1.62107011 |
| 114 | Vaginal atresia (HP:0000148) | 1.60907230 |
| 115 | Interstitial pulmonary disease (HP:0006530) | 1.57828258 |
| 116 | Genital tract atresia (HP:0001827) | 1.54870703 |
| 117 | Severe Myopia (HP:0011003) | 1.46796377 |
| 118 | True hermaphroditism (HP:0010459) | 1.45946867 |
| 119 | Pancreatic fibrosis (HP:0100732) | 1.42939704 |
| 120 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.36873824 |
| 121 | Dysdiadochokinesis (HP:0002075) | 1.32355104 |
| 122 | Abnormality of the fovea (HP:0000493) | 1.25791480 |
| 123 | Epileptic encephalopathy (HP:0200134) | 1.24306389 |
| 124 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.20407503 |
| 125 | Hypoplasia of the fovea (HP:0007750) | 1.20407503 |
| 126 | Astigmatism (HP:0000483) | 1.15572391 |
| 127 | Febrile seizures (HP:0002373) | 1.15442452 |
| 128 | Pancreatic cysts (HP:0001737) | 1.12943962 |
| 129 | Cystic liver disease (HP:0006706) | 1.12177303 |
| 130 | Progressive cerebellar ataxia (HP:0002073) | 1.01609804 |
| 131 | Recurrent sinusitis (HP:0011108) | 1.01392896 |
| 132 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 0.97409203 |
| 133 | Truncal ataxia (HP:0002078) | 0.96415531 |
| 134 | Specific learning disability (HP:0001328) | 0.93152495 |
| 135 | Aplasia/Hypoplasia of the macula (HP:0008059) | 0.92826120 |
| 136 | Left ventricular hypertrophy (HP:0001712) | 0.92447916 |
| 137 | Broad foot (HP:0001769) | 0.92017456 |
| 138 | Sclerocornea (HP:0000647) | 0.90105499 |
| 139 | Visual hallucinations (HP:0002367) | 0.89942582 |
| 140 | Hypermetropia (HP:0000540) | 0.87920822 |
| 141 | Asthma (HP:0002099) | 0.87554642 |
| 142 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 0.85333036 |
| 143 | Decreased testicular size (HP:0008734) | 0.84011901 |
| 144 | Genetic anticipation (HP:0003743) | 0.82630197 |
| 145 | Molar tooth sign on MRI (HP:0002419) | 0.80905995 |
| 146 | Abnormality of midbrain morphology (HP:0002418) | 0.80905995 |
| 147 | Furrowed tongue (HP:0000221) | 0.79619120 |
| 148 | Prolonged QT interval (HP:0001657) | 0.77843554 |
| 149 | * Retinal detachment (HP:0000541) | 0.76764148 |
| 150 | Cerebellar dysplasia (HP:0007033) | 0.75517205 |
| 151 | Abnormality of dental color (HP:0011073) | 0.72205120 |
| 152 | Anencephaly (HP:0002323) | 0.71057470 |
| 153 | Broad-based gait (HP:0002136) | 0.70720900 |
| 154 | Chronic hepatic failure (HP:0100626) | 0.69315052 |
| 155 | Congenital hepatic fibrosis (HP:0002612) | 0.68369118 |
| 156 | Postaxial hand polydactyly (HP:0001162) | 0.67843547 |
| 157 | Lymphopenia (HP:0001888) | 0.66467793 |
| 158 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 0.66079258 |
| 159 | Dental crowding (HP:0000678) | 0.65777704 |
| 160 | Hypodontia (HP:0000668) | 0.65744348 |
| 161 | Short foot (HP:0001773) | 0.64730973 |
| 162 | Abnormality of the fingertips (HP:0001211) | 0.63495909 |
| 163 | Corneal dystrophy (HP:0001131) | 0.62604316 |
| 164 | Gaze-evoked nystagmus (HP:0000640) | 0.61703929 |
| 165 | Abnormal EKG (HP:0003115) | 0.60611245 |
| 166 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 0.59743677 |
| 167 | Generalized myoclonic seizures (HP:0002123) | 0.59259883 |
| 168 | Nephronophthisis (HP:0000090) | 0.59158075 |
| 169 | Postaxial foot polydactyly (HP:0001830) | 0.59149250 |
| 170 | Partial agenesis of the corpus callosum (HP:0001338) | 0.58891657 |
| 171 | Macroorchidism (HP:0000053) | 0.57006726 |
| 172 | Syncope (HP:0001279) | 0.56897107 |
| 173 | Aqueductal stenosis (HP:0002410) | 0.56851646 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PBK | 6.08415447 |
| 2 | WNK3 | 4.47541403 |
| 3 | PINK1 | 3.21027474 |
| 4 | MAP3K9 | 3.06492405 |
| 5 | TNIK | 2.85533279 |
| 6 | IRAK2 | 2.42578650 |
| 7 | TRIM28 | 2.12483841 |
| 8 | GRK1 | 11.8005184 |
| 9 | DYRK2 | 1.89365281 |
| 10 | CDK19 | 1.87498733 |
| 11 | SIK2 | 1.70807742 |
| 12 | ADRBK1 | 1.55570619 |
| 13 | BMPR1B | 1.54520123 |
| 14 | CAMK1G | 1.53217335 |
| 15 | EPHA4 | 1.52583729 |
| 16 | CSNK1G3 | 1.46496621 |
| 17 | CSNK1G2 | 1.45041518 |
| 18 | MAP3K10 | 1.38594186 |
| 19 | MAPK12 | 1.37413779 |
| 20 | TAOK2 | 1.37382401 |
| 21 | MAPK7 | 1.37198401 |
| 22 | BRAF | 1.36585349 |
| 23 | INSRR | 1.31376239 |
| 24 | CAMK1D | 1.31069570 |
| 25 | BRD4 | 1.29203733 |
| 26 | HIPK2 | 1.26140934 |
| 27 | CDK12 | 1.25157912 |
| 28 | SGK223 | 1.23943770 |
| 29 | SGK494 | 1.23943770 |
| 30 | CSNK1G1 | 1.23425304 |
| 31 | ARAF | 1.21374169 |
| 32 | MARK1 | 1.20140965 |
| 33 | DMPK | 1.19708789 |
| 34 | MAP3K4 | 1.18480609 |
| 35 | PTK2B | 1.17442927 |
| 36 | PAK3 | 1.17257154 |
| 37 | SGK2 | 1.12613374 |
| 38 | CSNK1A1L | 1.12222697 |
| 39 | CSNK1D | 1.12072357 |
| 40 | AKT3 | 1.10488526 |
| 41 | TAOK3 | 1.09446599 |
| 42 | PAK6 | 1.07991481 |
| 43 | PNCK | 1.07305719 |
| 44 | KSR1 | 1.04542413 |
| 45 | PRKD3 | 1.03184673 |
| 46 | PRKCH | 1.02622851 |
| 47 | STK38 | 1.01954890 |
| 48 | OXSR1 | 0.99568423 |
| 49 | ERBB2 | 0.93813975 |
| 50 | SGK3 | 0.92619034 |
| 51 | RPS6KA4 | 0.91107337 |
| 52 | WNK1 | 0.88718010 |
| 53 | PRKCZ | 0.87331786 |
| 54 | CDK15 | 0.82854914 |
| 55 | STK16 | 0.82102118 |
| 56 | LATS2 | 0.81944200 |
| 57 | TYRO3 | 0.81591466 |
| 58 | CDK18 | 0.80528756 |
| 59 | ICK | 0.80471970 |
| 60 | CAMKK1 | 0.78621050 |
| 61 | DYRK1A | 0.77025154 |
| 62 | PRKCE | 0.76237252 |
| 63 | CDK11A | 0.75897874 |
| 64 | CDK14 | 0.75207100 |
| 65 | PRKCB | 0.73484287 |
| 66 | PLK2 | 0.72863224 |
| 67 | LATS1 | 0.71794152 |
| 68 | CDK3 | 0.71220725 |
| 69 | FES | 0.71003869 |
| 70 | CAMK2D | 0.70186344 |
| 71 | MAP2K7 | 0.69928982 |
| 72 | GRK5 | 0.69884704 |
| 73 | PRKCI | 0.69576318 |
| 74 | UHMK1 | 0.69007081 |
| 75 | EPHB2 | 0.68031133 |
| 76 | PRKAA1 | 0.67739328 |
| 77 | CASK | 0.67294988 |
| 78 | MAP3K13 | 0.66919430 |
| 79 | ADRBK2 | 0.65836395 |
| 80 | PRKAA2 | 0.62359560 |
| 81 | BCR | 0.60885237 |
| 82 | PRKACG | 0.60828536 |
| 83 | NEK6 | 0.59892179 |
| 84 | RPS6KA3 | 0.57828490 |
| 85 | TTK | 0.55624819 |
| 86 | SGK1 | 0.55356447 |
| 87 | MYLK | 0.54961585 |
| 88 | MAPKAPK5 | 0.52517703 |
| 89 | CSNK1A1 | 0.51979978 |
| 90 | MOS | 0.51809264 |
| 91 | CAMK2B | 0.51610448 |
| 92 | CDK5 | 0.50294595 |
| 93 | PKN1 | 0.49897836 |
| 94 | ZAK | 0.49732775 |
| 95 | MAPKAPK3 | 0.49066622 |
| 96 | PRKD2 | 0.48788868 |
| 97 | PRKCQ | 0.47832866 |
| 98 | CAMK1 | 0.47251755 |
| 99 | CDK9 | 0.47092897 |
| 100 | MAP3K12 | 0.46606475 |
| 101 | TAOK1 | 0.46506366 |
| 102 | GSK3B | 0.46187399 |
| 103 | AURKA | 0.45581976 |
| 104 | PRKDC | 0.45408151 |
| 105 | NUAK1 | 0.43703548 |
| 106 | MAPK14 | 0.42919110 |
| 107 | MAPK10 | 0.42774339 |
| 108 | NTRK3 | 0.41424357 |
| 109 | PRPF4B | 0.40908379 |
| 110 | CAMK4 | 0.40090764 |
| 111 | CAMK2A | 0.40088687 |
| 112 | NEK1 | 0.39252699 |
| 113 | DYRK1B | 0.39019883 |
| 114 | MAPK9 | 0.38382276 |
| 115 | STK11 | 0.38093163 |
| 116 | MAP4K2 | 0.37296819 |
| 117 | PHKG1 | 0.37075316 |
| 118 | PHKG2 | 0.37075316 |
| 119 | PRKCG | 0.37042811 |
| 120 | ACVR1B | 0.36956582 |
| 121 | PIK3CA | 0.36373243 |
| 122 | PLK3 | 0.36370514 |
| 123 | MAP2K4 | 0.36296057 |
| 124 | EPHA3 | 0.35435598 |
| 125 | PRKACA | 0.35083610 |
| 126 | MKNK2 | 0.34665715 |
| 127 | MARK3 | 0.34287732 |
| 128 | FRK | 0.33832632 |
| 129 | CAMK2G | 0.33783613 |
| 130 | CDK1 | 0.33595667 |
| 131 | MAP3K7 | 0.33178778 |
| 132 | AKT2 | 0.32961925 |
| 133 | PLK1 | 0.32711152 |
| 134 | PRKACB | 0.31543923 |
| 135 | NTRK2 | 0.31145034 |
| 136 | MAPK13 | 0.31087129 |
| 137 | RPS6KB1 | 0.30145873 |
| 138 | MINK1 | 0.29636369 |
| 139 | PRKCA | 0.28853097 |
| 140 | YES1 | 0.26544894 |
| 141 | SIK1 | 0.25643560 |
| 142 | PDK2 | 0.23925382 |
| 143 | WNK4 | 0.23034178 |
| 144 | MAPK8 | 0.22317134 |
| 145 | NEK2 | 0.21890974 |
| 146 | STK39 | 0.21484414 |
| 147 | CSNK1E | 0.21031383 |
| 148 | ATM | 0.20780924 |
| 149 | PRKG1 | 0.20311552 |
| 150 | MAPK3 | 0.19787011 |
| 151 | CHEK2 | 0.19176995 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.15864558 |
| 2 | Phototransduction_Homo sapiens_hsa04744 | 15.9316749 |
| 3 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.89103390 |
| 4 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.80430981 |
| 5 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.58918743 |
| 6 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.57243286 |
| 7 | Basal transcription factors_Homo sapiens_hsa03022 | 1.51611840 |
| 8 | Olfactory transduction_Homo sapiens_hsa04740 | 1.48148385 |
| 9 | Parkinsons disease_Homo sapiens_hsa05012 | 1.45776375 |
| 10 | Long-term depression_Homo sapiens_hsa04730 | 1.45355602 |
| 11 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.36289552 |
| 12 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.32262742 |
| 13 | GABAergic synapse_Homo sapiens_hsa04727 | 1.22818175 |
| 14 | Huntingtons disease_Homo sapiens_hsa05016 | 1.18914674 |
| 15 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.18750240 |
| 16 | Gap junction_Homo sapiens_hsa04540 | 1.05596189 |
| 17 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.05345974 |
| 18 | Sulfur relay system_Homo sapiens_hsa04122 | 1.04176119 |
| 19 | Axon guidance_Homo sapiens_hsa04360 | 1.02364437 |
| 20 | Alzheimers disease_Homo sapiens_hsa05010 | 0.99223483 |
| 21 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.93522159 |
| 22 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.93042595 |
| 23 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.90854633 |
| 24 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.88751060 |
| 25 | Retinol metabolism_Homo sapiens_hsa00830 | 0.87977196 |
| 26 | Morphine addiction_Homo sapiens_hsa05032 | 0.87721429 |
| 27 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.87142012 |
| 28 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.86586474 |
| 29 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.85357033 |
| 30 | Circadian rhythm_Homo sapiens_hsa04710 | 0.85168890 |
| 31 | Circadian entrainment_Homo sapiens_hsa04713 | 0.84698227 |
| 32 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.81495867 |
| 33 | Protein export_Homo sapiens_hsa03060 | 0.79112268 |
| 34 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.78138694 |
| 35 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.76540823 |
| 36 | Ribosome_Homo sapiens_hsa03010 | 0.71254593 |
| 37 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.70542856 |
| 38 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.69776892 |
| 39 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.68919078 |
| 40 | ABC transporters_Homo sapiens_hsa02010 | 0.67089468 |
| 41 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.65101603 |
| 42 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.63790303 |
| 43 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.61228815 |
| 44 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.60346266 |
| 45 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.59959256 |
| 46 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.59829914 |
| 47 | Nicotine addiction_Homo sapiens_hsa05033 | 0.57632193 |
| 48 | Insulin secretion_Homo sapiens_hsa04911 | 0.57557291 |
| 49 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.53295032 |
| 50 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.52997005 |
| 51 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.51304012 |
| 52 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.48442302 |
| 53 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.47914736 |
| 54 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.46539347 |
| 55 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.46503791 |
| 56 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.46220755 |
| 57 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.45955613 |
| 58 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.45668762 |
| 59 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.42942679 |
| 60 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.41821916 |
| 61 | Prion diseases_Homo sapiens_hsa05020 | 0.40835955 |
| 62 | Purine metabolism_Homo sapiens_hsa00230 | 0.40304106 |
| 63 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.38991757 |
| 64 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.38809447 |
| 65 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.38213426 |
| 66 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.38016293 |
| 67 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.37261195 |
| 68 | Renin secretion_Homo sapiens_hsa04924 | 0.35708665 |
| 69 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.35280017 |
| 70 | Salivary secretion_Homo sapiens_hsa04970 | 0.35271729 |
| 71 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.35160688 |
| 72 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.33509256 |
| 73 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.32893422 |
| 74 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.32633142 |
| 75 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.32508853 |
| 76 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.30214432 |
| 77 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.29715656 |
| 78 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.28604701 |
| 79 | Cocaine addiction_Homo sapiens_hsa05030 | 0.28527908 |
| 80 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.28486296 |
| 81 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.28239281 |
| 82 | Long-term potentiation_Homo sapiens_hsa04720 | 0.27942400 |
| 83 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.27504607 |
| 84 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.27448262 |
| 85 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.27033556 |
| 86 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.26978632 |
| 87 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.26946875 |
| 88 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.25631308 |
| 89 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.24594066 |
| 90 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.24466732 |
| 91 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.23113963 |
| 92 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.21540639 |
| 93 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.21264760 |
| 94 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.20833648 |
| 95 | Lysine degradation_Homo sapiens_hsa00310 | 0.20279661 |
| 96 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.18920858 |
| 97 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.18586946 |
| 98 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.16646716 |
| 99 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.16613368 |
| 100 | Alcoholism_Homo sapiens_hsa05034 | 0.16515646 |
| 101 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.15495994 |
| 102 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.15258959 |
| 103 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.14870107 |
| 104 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.14754643 |
| 105 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.13848431 |
| 106 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.13803195 |
| 107 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.13219954 |
| 108 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.13217800 |
| 109 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.12515837 |
| 110 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.12305605 |
| 111 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.11738078 |
| 112 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.11618589 |
| 113 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.11546677 |
| 114 | Tight junction_Homo sapiens_hsa04530 | 0.11212269 |
| 115 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.10632160 |
| 116 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.09787777 |
| 117 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.09784886 |
| 118 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.09672169 |
| 119 | Bile secretion_Homo sapiens_hsa04976 | 0.09593863 |
| 120 | Mineral absorption_Homo sapiens_hsa04978 | 0.09459565 |
| 121 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.08942778 |
| 122 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.08656737 |
| 123 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.08160995 |
| 124 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.07963792 |
| 125 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.06877686 |
| 126 | Taste transduction_Homo sapiens_hsa04742 | 0.06690328 |
| 127 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.06664389 |
| 128 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.06655560 |
| 129 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.06591669 |
| 130 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.06269254 |
| 131 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.05789888 |
| 132 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.05585634 |
| 133 | Glioma_Homo sapiens_hsa05214 | 0.05559141 |
| 134 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.04385321 |
| 135 | Galactose metabolism_Homo sapiens_hsa00052 | 0.04124601 |
| 136 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.03941498 |
| 137 | Insulin resistance_Homo sapiens_hsa04931 | 0.03868883 |
| 138 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.03497756 |
| 139 | Melanogenesis_Homo sapiens_hsa04916 | 0.03460420 |

